Sorted By:

Relevance


List of 2017 Medicines in Development for Mental Illness

PhRMA  |  Report

This report outlines the medicines in development for mental illness including the drug name, sponsor, indication and development phase.
https://www.phrma.org/report/list-of-2017-medicines-in-development-for-mental-illness

PhRMA Comments on the 2010 Special 301 Report

PhRMA  |  Press Release

To delay these reviews undermines their efficacy and the value of the 301 report itself.
https://www.phrma.org/press-release/phrma-comments-on-the-2010-special-301-report

Medicines in Development for Infectious Diseases 2013 Report

PhRMA  |  Report

Throughout history, infectious diseases have taken a devastating toll on the lives and well-being of people around the world. Caused when pathogens such as bacteria or viruses enter a body and multiply, infectious diseases were the leading cause of death in the United States until the 1920s. Toda...
https://www.phrma.org

Statement Regarding GAO Report on Drug Prices

PhRMA  |  Press Release

Reports that ignore this fact exaggerate drug price trends and miss the point that it is the innovators investments that lead to pioneering advances that improve patient care – and over time it is the innovators investments in new brand medicines that lead to generic copies that are broadly used by patients at low cost for many years.
https://www.phrma.org/press-release/statement-regarding-gao-report-on-drug-prices

Chart Pack: Cancer Medicines Value in Context

PhRMA  |  Report

Data and information found in this publication were drawn from a wide range of sources, including government agency reports, peer-reviewed journals, and the Pharmaceutical Research and Manufacturers of America’s (PhRMA’s) own research and analysis.
https://www.phrma.org/report/chart-pack-cancer-medicines-value-in-context

Australia is making it harder to protect inventions. That’s bad for American businesses and jobs.

PhRMA  |  Blog Post

Unfortunately, Australia is discouraging inventors from seeking injunctions to stop products that may violate a patent from entering the market.
http://catalyst.phrma.org/australia-is-making-it-harder-to-protect-inventions.-thats-bad-for-american-businesses-and-jobs

New Report Shows Minnesota Clinical Trials Benefit Patients, State Economy and Science

PhRMA  |  Press Release

For more information on the "Research in Your Backyard" report, including locations of Minnesota clinical trials, click here.     
https://www.phrma.org/press-release/new-report-shows-minnesota-clinical-trials-benefit-patients-state-economy-and-science

New Report: Forecasts for Specialty Medicines Have Been Overstated

PhRMA  |  Blog Post

Given the findings of the Milliman report, it seems clear that PBM forecasts for selected subsets of prescription medicines should be interpreted with caution.
http://catalyst.phrma.org/new-report-forecasts-for-specialty-medicines-have-been-overstated

Medicines in Development for Autoimmune Diseases 2016 Report

PhRMA  |  Report

View the Full Report  
https://www.phrma.org/report/medicines-in-development-for-autoimmune-diseases-2016-report

Mental Health Medicines in Development Report, 2014

PhRMA  |  Report

Mental health conditions exact a heavy human and economic toll in the United States. The National Institute of Mental Health (NIMH) estimates that 1 in 4 American adults—61.5 million—have been diagnosed with a mental health disorder. According to the NIMH, serious mental illnesses cost the United...
https://www.phrma.org/report/mental-health-medicines-in-development-report-2014

PhRMA Statement on 2013 Special 301 Report

PhRMA  |  Press Release

WASHINGTON, D.C. (May 1, 2013) – Pharmaceutical Research and Manufacturers of America (PhRMA) International Vice President Jay Taylor issued the following statement today: Maintaining global incentives for research and development into new medicines is essential for contin...
https://www.phrma.org/press-release/phrma-statement-on-2013-special-301-report

Medicines in Development for Older Americans 2013 Report

PhRMA  |  Report

This report lists medicines and vaccines in human clinical trials or under review by the U.S.
https://www.phrma.org/report/medicines-in-development-for-older-americans-2013-report

Moran Company Study on Hospital Markups of Medicines

PhRMA  |  Report

This report by the Moran Company identifies this hidden threat to affordability that is a driver of higher cost sharing and premiums for patients across the country.
https://www.phrma.org/report/moran-company-study-on-hospital-markups-of-medicines

Medicines in Development for Mental Illnesses - 2012 Report

PhRMA  |  Report

America’s biopharmaceutical research companies are developing 187 medicines to help the nearly 60 million American adults now suffering from some form of mental illness—from anxiety to depression and from schizophrenia to addictive disorders, such as dependence on alcohol or drugs. All of the med...
https://www.phrma.org/report/medicines-in-development-for-mental-illnesses-2012-report

Medicines in Development for Leukemia & Lymphoma 2015 Report

PhRMA  |  Report

Each year, more than 162,000 Americans are diagnosed with a blood cancer—accounting for more than 9 percent of all new cancer diagnoses. Major types of blood cancers include leukemia, lymphoma and myeloma....
https://www.phrma.org/report/medicines-in-development-for-leukemia-and-lymphoma-2015-report

Medicare Monday: What is in the 2016 Medicare Trustees report

PhRMA  |  Blog Post

While this year’s report pushed off triggering IPAB for another year, it remains a serious threat to seniors and could come between patients and their health care providers.
http://catalyst.phrma.org/medicare-monday-what-is-in-the-2016-medicare-trustees-report

IMS Health Report Finds Medicines Helping Bend the Health Care Cost Curve

PhRMA  |  Press Release

But media reports often fail to acknowledge that there are inequities in insurance coverage for different types of health care services, and that chronically ill patients are often expected to pay more in out-of-pocket expenses for their medicines than for other types of health care, such as hospitalizations.
https://www.phrma.org/press-release/ims-health-report-finds-medicines-helping-bend-the-health-care-cost-curve

PhRMA Statement on PCAST Innovation Report

PhRMA  |  Press Release

“This report couldn’t have come at a better time andwe look forward to having discussions with members of the new Congress and the Administration on steps we can take to help ensure the U.S. remains the world leader in medical innovation.”
https://www.phrma.org/press-release/phrma-statement-on-pcast-innovation-report

New Report Highlights a Decade of Innovation in Rare Diseases

PhRMA  |  Blog Post

A new report, A Decade of Innovation in Rare Diseases, highlights advances made in the last ten years against a variety of rare diseases, providing new treatments for patients who need them.
http://catalyst.phrma.org/new-report-highlights-a-decade-of-innovation-in-rare-diseases

New report highlights impact of intellectual property on U.S. economy

PhRMA  |  Blog Post

A report by NDP Analytics found that between 2000 and 2010, R&D investment in the pharmaceutical manufacturing industry accounted for 27% of all R&D investment among IP-intensive industries.
http://catalyst.phrma.org/new-report-highlights-impact-of-intellectual-property-on-u.s.-economy

New report: Decade of breakthroughs in cancer

PhRMA  |  Blog Post

Here are some highlights from the report: Melanoma: A wave of immunotherapies has transformed the treatment of the metastatic disease.
http://catalyst.phrma.org/new-report-decade-of-breakthroughs-in-cancer

New report highlights more than 250 vaccines in development

PhRMA  |  Blog Post

View the full report here.
http://catalyst.phrma.org/new-report-highlights-more-than-250-vaccines-in-development

New report highlights need to speed patent examination

PhRMA  |  Blog Post

The report found that while every country faces its own unique problems related to the backlog of patent applications, new trends and leaders in patent innovation have emerged.
http://catalyst.phrma.org/new-report-highlights-need-to-speed-patent-examination

New PhRMA Report: Medicines in development for patients with rare diseases demonstrate the promise of innovation

PhRMA  |  Blog Post


http://catalyst.phrma.org/new-phrma-report-medicines-in-development-for-patients-with-rare-diseases-demonstrate-the-promise-of-innovation

Medicines in Development for Skin Diseases 2011 Report

PhRMA  |  Report

America’s biopharmaceutical research companies are currently developing 277 medicines to help the more than 100 million Americans—one-third of the U.S. population—afflicted with at least one skin disease, ranging from acne to melanoma. All of the medicines are either in clinical trials or awaitin...
https://www.phrma.org/report/medicines-in-development-for-skin-diseases

You have reviewed the first 125 results out of 1012. Each page contains 25 results. You're on page 5.

prev 1 2 3 4 5 6 next